BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18551403)

  • 1. Identification of COL6A1 as a differentially expressed gene in human astrocytomas.
    Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC
    Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
    Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
    Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
    Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
    Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
    Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
    Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
    BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
    Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
    Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
    Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
    Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
    Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):275-81. PubMed ID: 11895042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy.
    Comincini S; Ferrara V; Arias A; Malovini A; Azzalin A; Ferretti L; Benericetti E; Cardarelli M; Gerosa M; Passarin MG; Turazzi S; Bellazzi R
    Oncol Rep; 2007 May; 17(5):989-96. PubMed ID: 17390034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.